BIOINFORMATICS ANALYSIS OF GENE EXPRESSION PATTERNS IN BREAST CANCER

Authors

  • Dr. Aisha Al Mansoori
  • Dr. Omar Khalid Al Nuaimi
  • Dr. Sara Ahmed Al Kaabi
  • Dr. Reem Abdullah Al Mazrouei
  • Dr. Hanan Saif Al Shehhi

Abstract

Breast cancer is one of the leading causes of cancer-related mortality among women worldwide and is characterized by substantial molecular heterogeneity. The present study aimed to analyse gene expression patterns associated with breast cancer using bioinformatics approaches and to identify potential molecular biomarkers related to different breast cancer subtypes. A publicly available microarray dataset, Breast_GSE45827, consisting of 151 samples and more than 54,000 gene expression features, was utilized for computational analysis. The dataset included normal breast tissue samples and multiple breast cancer subtypes, including basal, HER2-positive, luminal A, luminal B, and cell line samples. Data preprocessing and normalization procedures were performed to improve dataset quality and comparability among samples. Exploratory data analysis, differential gene expression analysis, Principal Component Analysis (PCA), and hierarchical clustering were subsequently conducted to investigate molecular expression patterns and subtype-specific variations. Several significantly dysregulated genes associated with tumour progression, cell proliferation, immune response, and metastasis were identified. PCA and clustering analyses demonstrated distinct molecular signatures among breast cancer subtypes, particularly within basal and HER2-positive groups. The analysis also identified potential biomarker genes that may contribute to breast cancer diagnosis, prognosis, and personalized therapeutic strategies. The findings highlighted the effectiveness of bioinformatics methods in analysing large-scale genomic datasets and identifying clinically relevant molecular targets in breast cancer. The present study contributes to the understanding of breast cancer molecular mechanisms and supports the potential application of computational biology approaches in biomarker
discovery and cancer genomics research.

Downloads

Download data is not yet available.

References

Chen, W. Q., Yang, S. J., Xu, W. X., Deng, F., Wang, D. D., & Tang, J. H. (2021). Bioinformatics analysis revealing

prognostic significance of TIMP2 gene in breast cancer. Medicine, 100(42), e27489.

Fiscon, G., Funari, A., & Paci, P. (2023). Circular RNA mediated gene regulation in human breast cancer: A

bioinformatics analysis. Plos one, 18(7), e0289051.

Golestan, A., Tahmasebi, A., Maghsoodi, N., Faraji, S. N., Irajie, C., & Ramezani, A. (2024). Unveiling promising

breast cancer biomarkers: an integrative approach combining bioinformatics analysis and experimental

verification. BMC cancer, 24(1), 155.

Grisci, B. (2020). Breast cancer gene expression - CuMiDa [Data set]. Kaggle.

https://www.kaggle.com/datasets/brunogrisci/breast-cancer-gene-expression-cumida

Hozhabri, H., Moghaddam, M. M., Moghaddam, M. M., & Mohammadian, A. (2022). A comprehensive

bioinformatics analysis to identify potential prognostic biomarkers among CC and CXC chemokines in breast

cancer. Scientific Reports, 12(1), 10374.

Li, C., Cui, J., Zou, L., Zhu, L., & Wei, W. (2020). Bioinformatics analysis of the expression of HOXC13 and its role

in the prognosis of breast cancer. Oncology letters, 19(1), 899-907.

Li, X., Gou, J., Li, H., & Yang, X. (2020). Bioinformatic analysis of the expression and prognostic value of chromobox

family proteins in human breast cancer. Scientific reports, 10(1), 17739.

Liang, Z., Wang, X., Dong, K., Li, X., Qin, C., & Zhou, H. (2021). Expression pattern and prognostic value of

EPHA/EFNA in breast cancer by bioinformatics analysis: revealing its importance in chemotherapy. BioMed Research

International, 2021(1), 5575704.

Lu, Y., Yang, G., Xiao, Y., Zhang, T., Su, F., Chang, R., ... & Bai, Y. (2020). Upregulated cyclins may be novel genes

for triple-negative breast cancer based on bioinformatic analysis. Breast Cancer, 27(5), 903-911.

Ma, J., Chen, C., Liu, S., Ji, J., Wu, D., Huang, P., ... & Ren, L. (2022). Identification of a five genes prognosis

signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis. Cancer Gene

Therapy, 29(11), 1578-1589.

Mehraj, U., Alshehri, B., Khan, A. A., Bhat, A. A., Bagga, P., Wani, N. A., & Mir, M. A. (2022). Expression pattern

and prognostic significance of chemokines in breast cancer: an integrated bioinformatics analysis. Clinical Breast

Cancer, 22(6), 567-578.

Mehraj, U., Sofi, S., Alshehri, B., & Mir, M. A. (2022). Expression pattern and prognostic significance of CDKs in

breast cancer: an integrated bioinformatic study. Cancer Biomarkers, 34(3), 505-519.

Mo, L., Liu, J., Yang, Z., Gong, X., Meng, F., Zou, R., ... & Fang, F. (2020). DNAJB4 identified as a potential breast

cancer marker: evidence from bioinformatics analysis and basic experiments. Gland Surgery, 9(6), 1955.

Ramos, S., Ferreira, S., Fernandes, A. S., & Saraiva, N. (2022). Lysyl oxidases expression and breast cancer

progression: a bioinformatic analysis. Frontiers in pharmacology, 13, 883998.

Ren, H., Hu, D., Mao, Y., & Su, X. (2020). Identification of genes with prognostic value in the breast cancer

microenvironment using bioinformatics analysis. Medical Science Monitor: International Medical Journal of

Experimental and Clinical Research, 26, e920212-1.

Rezaeijo, S. M., Rezaei, M., Poursheikhani, A., Mohammadkhani, S., Goharifar, N., Shayankia, G., ... & Taghizadeh,

E. (2023). Integrative bioinformatics analysis of miRNA and mRNA expression profiles identified some potential

biomarkers for breast cancer. Egyptian Journal of Medical Human Genetics, 24(1), 62.

Tian, Y., Liu, X., Hu, J., Zhang, H., Wang, B., Li, Y., ... & Yu, Y. (2021). Integrated bioinformatic analysis of the

expression and prognosis of caveolae-related genes in human breast cancer. Frontiers in Oncology, 11, 703501.

Wang, Y., Li, Y., Liu, B., & Song, A. (2021). Identifying breast cancer subtypes associated modules and biomarkers

by integrated bioinformatics analysis. Bioscience reports, 41(1), BSR20203200.

Wu, G., Xiao, G., Yan, Y., Guo, C., Hu, N., & Shen, S. (2022). Bioinformatics analysis of the clinical significance of

HLA class II in breast cancer. Medicine, 101(40), e31071.

Yadav, D. K., Sharma, A., Dube, P., Shaikh, S., Vaghasia, H., & Rawal, R. M. (2022). Identification of crucial hub

genes and potential molecular mechanisms in breast cancer by integrated bioinformatics analysis and experimental

validation. Computers in Biology and Medicine, 149, 106036.

Yan, S., & Yue, S. (2023). Identification of early diagnostic biomarkers for breast cancer through bioinformatics

analysis. Medicine, 102(37), e35273.

Zeng, C., Lin, M., Jin, Y., & Zhang, J. (2022). Identification of key genes associated with brain metastasis from breast

cancer: a bioinformatics analysis. Medical Science Monitor: International Medical Journal of Experimental and

Clinical Research, 28, e935071-1.

Zhang, M., Chen, H., Wang, M., Bai, F., & Wu, K. (2020). Bioinformatics analysis of prognostic significance of

COL10A1 in breast cancer. Bioscience reports, 40(2), BSR20193286.

Downloads

Published

2024-12-28

How to Cite

Al Mansoori, D. A., Khalid Al Nuaimi, D. O., Ahmed Al Kaabi, D. S., Abdullah Al Mazrouei, D. R., & Saif Al Shehhi, D. H. (2024). BIOINFORMATICS ANALYSIS OF GENE EXPRESSION PATTERNS IN BREAST CANCER. International Journal For Research In Biology & Pharmacy, 10(4), 01–08. Retrieved from https://ijrbp.com/index.php/bp/article/view/2497